Suppression of Ras transformation by serum response factor

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Serum response factor (SRF) is a transcription factor binding to serum response elements (SREs) in growth factor-inducible and muscle-specific genes.
• Smooth muscle alpha-actin expression is repressed in Ras-transformed cells and involves SRF binding to SREs in its promoter.

Purpose of the Study:

• To investigate the role of SRF in regulating alpha-actin expression in Ras-transformed cells.
• To determine if SRF can revert the transformed phenotype of fibroblast cells induced by Ras.
• To assess the importance of SRF's DNA-binding ability for its effects on alpha-actin expression and cell transformation.

Main Methods:

• Utilizing Ras-transformed fibroblast cells and revertant cells.
• Overexpressing SRF in Ras-transformed cells.
• Employing site-directed mutagenesis to disrupt SRF's DNA-binding capacity.

Main Results:

• SRF activates alpha-actin expression in Ras-transformed cells.
• Overexpression of SRF reverts the transformed phenotype of Ras-transformed cells.
• Mutations inhibiting SRF DNA binding abolish its ability to activate alpha-actin expression and suppress Ras-induced transformation.

Conclusions:

• SRF can activate alpha-actin expression and suppress Ras-induced cell transformation.
• SRF's DNA-binding activity is essential for its tumor-suppressive function.
• SRF may represent a novel target for cancer therapy, challenging its known role in promoting cell growth.